STAT Plus: Axovant failed. Now what? A collection of takes hot and cold
-
The biggest biotech trial of the year, Axovant's Alzheimer's drug, flopped.
STAT's senior biotech reporters walk you through the key takeaways.
57 minutes ago
Posts
2 comments:
We can also see the feeling of entitlement in the Nov. 3, 2010 WSJ article Insider Case Alleges Doctor’s Tips. The short version is we have two doctors trading information regarding an ongoing drug trial.
I cannot find the link but one doctor, Yale, was featured a few years ago decrying the fact that he found medicine to be mind numbing, dirty and not worth the $500,000.00 starting salary when he could make $5M at a hedge fund.
Ego and a sense of entitlement seem to be common traits in people involved in these situations.
Steve Lucas
Found the link:
http://www.margaretsoltan.com/?p=27234
University Diaries: One of the smellier stories coming out of…
Steve Lucas
Post a Comment